These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 33390852)

  • 21. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
    Leclercq S; de Timary P; Stärkel P
    Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Li H; Shi J; Zhao L; Guan J; Liu F; Huo G; Li B
    J Agric Food Chem; 2021 Jan; 69(1):183-197. PubMed ID: 33353302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis.
    Rohrhofer J; Zwirzitz B; Selberherr E; Untersmayr E
    Front Immunol; 2021; 12():635704. PubMed ID: 34054805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol or Gut Microbiota: Who Is the Guilty?
    Meroni M; Longo M; Dongiovanni P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment.
    Guo XY; Liu XJ; Hao JY
    J Dig Dis; 2020 Mar; 21(3):147-159. PubMed ID: 32040250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives.
    Hu H; Lin A; Kong M; Yao X; Yin M; Xia H; Ma J; Liu H
    J Gastroenterol; 2020 Feb; 55(2):142-158. PubMed ID: 31845054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between the intestinal microbiome and liver diseases.
    Schnabl B; Brenner DA
    Gastroenterology; 2014 May; 146(6):1513-24. PubMed ID: 24440671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bridging intestinal immunity and gut microbiota by metabolites.
    Wang G; Huang S; Wang Y; Cai S; Yu H; Liu H; Zeng X; Zhang G; Qiao S
    Cell Mol Life Sci; 2019 Oct; 76(20):3917-3937. PubMed ID: 31250035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
    Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
    Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut-liver axis in alcoholic liver disease.
    Szabo G
    Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiome and liver diseases.
    Tilg H; Cani PD; Mayer EA
    Gut; 2016 Dec; 65(12):2035-2044. PubMed ID: 27802157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related changes in intestinal immunity and the microbiome.
    Walrath T; Dyamenahalli KU; Hulsebus HJ; McCullough RL; Idrovo JP; Boe DM; McMahan RH; Kovacs EJ
    J Leukoc Biol; 2021 Jun; 109(6):1045-1061. PubMed ID: 33020981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
    Stärkel P; Leclercq S; de Timary P; Schnabl B
    Clin Sci (Lond); 2018 Jan; 132(2):199-212. PubMed ID: 29352076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease.
    Martín-Mateos R; Albillos A
    Front Immunol; 2021; 12():660179. PubMed ID: 33936094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host-microbiome interactions in alcoholic liver disease.
    Chen P; Schnabl B
    Gut Liver; 2014 May; 8(3):237-41. PubMed ID: 24827618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential mechanisms linking gut microbiota and portal hypertension.
    Baffy G
    Liver Int; 2019 Apr; 39(4):598-609. PubMed ID: 30312513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functions of innate immune cells and commensal bacteria in gut homeostasis.
    Kayama H; Takeda K
    J Biochem; 2016 Feb; 159(2):141-9. PubMed ID: 26615026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of intestinal epithelial cells in the maintenance of gut homeostasis.
    Okumura R; Takeda K
    Exp Mol Med; 2017 May; 49(5):e338. PubMed ID: 28546564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Camel milk ameliorates inflammatory mechanisms in an alcohol-induced liver injury mouse model.
    Ming L; Qi B; Hao S; Ji R
    Sci Rep; 2021 Nov; 11(1):22811. PubMed ID: 34819599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
    Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
    J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.